“…In SAH, acceptable sensitivities and specificities were demonstrated with CRP, selectin, thrombin antithrombin complex (TAT), creatine kinase-BB (CK-BB) and malondialdehyde (MDA) (83 versus 84%, 90 versus 83%, 72 versus 70%, 70 versus 100% and 88 versus 75%, respectively) (Coplin et al, 1999; Jeon et al, 2012; Kaneda et al, 2010; Morga et al, 2007; Wang et al, 2011). Although most of the sensitivities and specificities are not greater than 90%, each of these markers may be able to identify subjects that have poor outcome and those that will potentially recover well with some reasonableness.…”